We are live on ! Find out more
MDXG icon

MiMedx Group

223 hedge funds and large institutions have $602M invested in MiMedx Group in 2018 Q1 according to their latest regulatory filings, with 39 funds opening new positions, 73 increasing their positions, 68 reducing their positions, and 50 closing their positions.

New
Increased
Maintained
Reduced
Closed

7% more repeat investments, than reductions

Existing positions increased: 73 | Existing positions reduced: 68

6% less funds holding

Funds holding: 236223 (-13)

22% less first-time investments, than exits

New positions opened: 39 | Existing positions closed: 50

47% less capital invested

Capital invested by funds: $1.13B → $602M (-$525M)

66% less call options, than puts

Call options by funds: $12M | Put options by funds: $35.2M

100% less funds holding in top 10

Funds holding in top 10: 10 (-1)

Holders
223
Holders Change
-13
Holders Change %
-5.51%
% of All Funds
5.11%
Holding in Top 10
Holding in Top 10 Change
-1
Holding in Top 10 Change %
-100%
% of All Funds
New
39
Increased
73
Reduced
68
Closed
50
Calls
$12M
Puts
$35.2M
Net Calls
-$23.1M
Net Calls Change
-$6.71M
Name Holding Trade Value Shares
Change
Change in
Stake
Goldman Sachs
26
Goldman Sachs
New York
$4.47M +$1.46M +125,655 +24%
Charles Schwab
27
Charles Schwab
California
$4.25M -$92.8K -7,974 -1%
Royal Bank of Canada
28
Royal Bank of Canada
Ontario, Canada
$4.24M +$3.65M +313,657 +107%
TIM
29
Thompson Investment Management
Wisconsin
$3.93M +$2.64M +226,709 +67%
Ameriprise
30
Ameriprise
Minnesota
$3.71M -$1.03M -88,366 -14%
Invesco
31
Invesco
Georgia
$3.29M +$2.04M +175,624 +59%
PCM
32
Parsons Capital Management
Rhode Island
$3.27M +$658K +56,485 +14%
Allianz Asset Management
33
Allianz Asset Management
Germany
$3.25M -$324K -27,795 -6%
Thrivent Financial for Lutherans
34
Thrivent Financial for Lutherans
Minnesota
$3.2M -$2.01M -172,540 -27%
Nordea Investment Management
35
Nordea Investment Management
Sweden
$3.2M +$5.34M +459,050 New
SCA
36
Summit Creek Advisors
Minnesota
$3.09M -$984K -84,480 -16%
GC
37
Guggenheim Capital
Illinois
$2.98M -$1.67M -143,667 -25%
Citigroup
38
Citigroup
New York
$2.86M +$1.19M +102,006 +33%
MWNA
39
Marshall Wace North America
New York
$2.82M +$4.71M +404,532 New
Squarepoint
40
Squarepoint
New York
$2.8M +$3.04M +260,826 +185%
Morgan Stanley
41
Morgan Stanley
New York
$2.75M -$22.6M -1,945,156 -83%
Russell Investments Group
42
Russell Investments Group
United Kingdom
$2.56M -$683K -58,641 -14%
TFCM
43
Taylor Frigon Capital Management
Arizona
$2.45M +$4.09M +351,120 New
MWP
44
MYCIO Wealth Partners
Pennsylvania
$2.4M
Two Sigma Investments
45
Two Sigma Investments
New York
$2.2M +$2.68M +230,031 +267%
QI
46
QS Investors
New York
$2.16M -$221K -18,947 -6%
Bank of America
47
Bank of America
North Carolina
$2.1M -$1.49M -127,552 -30%
Two Sigma Advisers
48
Two Sigma Advisers
New York
$2.07M -$465K -39,900 -12%
QIM
49
Quantitative Investment Management
Virginia
$2.05M +$2.81M +241,400 +457%
GCP
50
GSA Capital Partners
United Kingdom
$2M +$925K +79,472 +38%

MDXG Hedge Fund Activity: Q1 2018 in Review

223 of the 4,364 institutional investors tracked by Wall St. Rank reported a position in MiMedx Group (MDXG) for Q1 2018, worth a combined $602M — down 47% from $1.13B a quarter earlier.

Sellers outnumbered buyers: 50 funds closed out of MDXG and 39 opened new positions — a net loss of 11 holders — while 68 trimmed existing stakes and 73 added.

The largest buyer was State Street, adding an estimated $37.2M. The largest seller was Consonance Capital Management, exiting entirely with an estimated $75.5M sold.

  • 223 institutional investors held MiMedx Group (MDXG) as of Q1 2018, down from 236 in Q4 2017.
  • Funds reported $602M of MiMedx Group stock for Q1 2018, down 47% quarter-over-quarter.
  • 39 funds opened new MiMedx Group positions in Q1 2018 and 50 closed out, a net change of -11 holders.
  • The largest MiMedx Group buyer in Q1 2018 was State Street, an estimated $37.2M added.
  • The largest MiMedx Group seller in Q1 2018 was Consonance Capital Management, an estimated $75.5M sold.

Based on aggregated 13F filings for Q1 2018.